CN110420154A - A kind of Anti-hair loss traditional Chinese medicine composition and the preparation method and application thereof - Google Patents
A kind of Anti-hair loss traditional Chinese medicine composition and the preparation method and application thereof Download PDFInfo
- Publication number
- CN110420154A CN110420154A CN201910805840.8A CN201910805840A CN110420154A CN 110420154 A CN110420154 A CN 110420154A CN 201910805840 A CN201910805840 A CN 201910805840A CN 110420154 A CN110420154 A CN 110420154A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- hair loss
- parts
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 124
- 239000000203 mixture Substances 0.000 title claims abstract description 109
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 230000003656 anti-hair-loss Effects 0.000 title claims description 58
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 16
- 210000004209 hair Anatomy 0.000 claims abstract description 16
- 229940010454 licorice Drugs 0.000 claims abstract description 16
- 235000005206 Hibiscus Nutrition 0.000 claims abstract description 15
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims abstract description 15
- 230000003658 preventing hair loss Effects 0.000 claims abstract description 12
- 210000004761 scalp Anatomy 0.000 claims description 27
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 26
- 239000002537 cosmetic Substances 0.000 claims description 25
- 239000000284 extract Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 241000202807 Glycyrrhiza Species 0.000 claims description 16
- 241000218033 Hibiscus Species 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 7
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 5
- 239000002453 shampoo Substances 0.000 claims description 5
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 25
- 201000004384 Alopecia Diseases 0.000 abstract description 18
- 208000024963 hair loss Diseases 0.000 abstract description 12
- 230000003676 hair loss Effects 0.000 abstract description 11
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 241000590988 Danainae Species 0.000 abstract description 2
- 208000001840 Dandruff Diseases 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 47
- 230000000052 comparative effect Effects 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- 239000000523 sample Substances 0.000 description 22
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 12
- 230000003637 steroidlike Effects 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 208000002874 Acne Vulgaris Diseases 0.000 description 8
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 8
- 206010000496 acne Diseases 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 231100000360 alopecia Toxicity 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 241000555676 Malassezia Species 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000001061 forehead Anatomy 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 206010016936 Folliculitis Diseases 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- -1 polyoxyethylene Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 229960003604 testosterone Drugs 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000555688 Malassezia furfur Species 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 210000004919 hair shaft Anatomy 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 2
- 230000003752 improving hair Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000588881 Chromobacterium Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 108010040897 Microfilament Proteins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 1
- 229960004199 dutasteride Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- ATWDUWYFCBVNET-UHFFFAOYSA-N ethylammonium methanesulfonate Chemical compound CC[NH3+].CS([O-])(=O)=O ATWDUWYFCBVNET-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- AMZGOPVHQLKMPR-UHFFFAOYSA-M methanesulfonate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound CS([O-])(=O)=O.CC(=C)C(=O)OCC[N+](C)(C)C AMZGOPVHQLKMPR-UHFFFAOYSA-M 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/008—Preparations for oily hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种防脱发中药组合物及其制备方法与应用。所述中药组合物由如下重量份的组分制成:射干5~50份;土槿皮5~35份;三颗针5~35份;徐长卿5~35份;甘草5~35份。本发明的中药组合物是以君臣佐使的中医组方理论为指导,各种组分按照特定比例进行搭配,达到协同增效作用,利用中药组合物的杀菌和控油功效去除头皮粉刺、治疗毛囊炎从而防脱发,利用中药组合物的活血功效赋活毛根从而促进毛发生长,利用中药组合物的抗菌作用和抗氧化作用达到去头皮屑功效,从而达到脱发综合治疗目标。The invention discloses a traditional Chinese medicine composition for preventing hair loss, a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 5-50 parts of shegan; 5-35 parts of hibiscus bark; 5-35 parts of three needles; 5-35 parts of Xu Changqing; and 5-35 parts of licorice. The traditional Chinese medicine composition of the present invention is guided by the traditional Chinese medicine prescription theory of monarchs, ministers and assistants. Various components are matched according to specific ratios to achieve synergistic effects. To prevent hair loss, use the blood-activating effect of the traditional Chinese medicine composition to revitalize the hair root to promote hair growth, and use the antibacterial and anti-oxidant effects of the traditional Chinese medicine composition to achieve the effect of anti-dandruff, so as to achieve the comprehensive treatment goal of hair loss.
Description
技术领域technical field
本发明属于化妆品领域,具体涉及一种防脱发中药组合物及其制备方法与应用。The invention belongs to the field of cosmetics, and in particular relates to a traditional Chinese medicine composition for preventing hair loss, a preparation method and application thereof.
背景技术Background technique
随着人们的生活水平和生活品质的不断提高,消费者对日常生活必备的美容护肤品的要求越来越高,越来越注重“回归自然”倾向植物护肤理念的影响。With the continuous improvement of people's living standards and quality of life, consumers have higher and higher requirements for beauty and skin care products necessary for daily life, and pay more and more attention to the influence of the concept of "returning to nature" and tending to plant skin care.
近年来,由于人们生活节奏加快、熬夜、饮食不规律、烫染头发以及环境污染等因素,导致头皮健康问题日益突出。中国健康教育协会头皮健康研究中心的数据显示,我国60%以上的成年人的头皮都存在不同程度的健康问题。其中最严重的头皮问题就是脱发问题。In recent years, due to factors such as people's accelerated pace of life, staying up late, irregular diet, dyed hair, and environmental pollution, scalp health problems have become increasingly prominent. According to data from the Scalp Health Research Center of the China Health Education Association, more than 60% of adults in my country have different degrees of health problems on their scalps. One of the most serious scalp problems is hair loss.
脱发主要分为两种:生理性的脱发和脂溢性的脱发。生理性的脱发往往是由于头皮组织肌肉层的萎缩而变薄,使得微丝血管网络血流量减少变慢,随着年龄的增长会越发的明显。脂溢性脱发是由于皮脂腺体受体内雄性激素影响而出现增生肥大的症状包裹住发根,发根无法提供足够的营养给发干,发干会出现营养的断流而脱发;特别是随着头皮油脂排泄量增多,感染引起头皮头皮粉刺和毛囊炎,破坏毛囊引起永久性脱发。所以科学的防脱发方法应该从控油、抑制马拉色菌生长、清除炎症、促进血液循环等多方面着手进行综合治疗。Alopecia is mainly divided into two types: physiological alopecia and seborrheic alopecia. Physiological hair loss is often due to the atrophy and thinning of the muscle layer of the scalp tissue, which makes the blood flow of the microfilament vascular network decrease and slow down, which will become more obvious with age. Seborrheic alopecia is a symptom of hyperplasia and hypertrophy due to the influence of androgen in the sebaceous gland receptors, which wraps the hair root, and the hair root cannot provide enough nutrition to the hair shaft, and the hair shaft will suffer from nutritional cut-off and hair loss; Scalp oil excretion increases, infection causes scalp acne and folliculitis, damages hair follicles and causes permanent hair loss. Therefore, the scientific anti-hair loss method should carry out comprehensive treatment from the aspects of oil control, inhibiting the growth of Malassezia, clearing inflammation, and promoting blood circulation.
目前防脱发的药物还是以化学物质为主,如非那雄胺、爱普列特、依立雄胺、度他雄胺、酮康唑等西药成分,但西药成分刺激性大、副作用大,不能用于化妆品中。为了克服化学物质的缺陷,本发明则采用对人体刺激性低、毒性低的中药组合物作为防脱发活性物,达到防脱发的目的。At present, the anti-hair loss drugs are still mainly chemical substances, such as finasteride, apretide, eristide, dutasteride, ketoconazole and other western medicine ingredients, but the western medicine ingredients are very irritating and have great side effects, so they cannot be used. Used in cosmetics. In order to overcome the defects of chemical substances, the present invention uses a traditional Chinese medicine composition with low irritation to human body and low toxicity as the anti-hair loss active substance to achieve the purpose of anti-hair loss.
发明内容Contents of the invention
为解决现有技术的缺点和不足之处,本发明的首要目的在于提供一种防脱发中药组合物。本发明以君臣佐使的中医理论为依据,提供一种具有控油、抑制马拉色菌生长、清除炎症、促进血液循环功效的防脱发中药组合物。In order to solve the shortcomings and deficiencies of the prior art, the primary purpose of the present invention is to provide a Chinese medicine composition for preventing hair loss. Based on the TCM theory of monarchs, ministers, assistants and envoys, the invention provides an anti-hair loss traditional Chinese medicine composition which has the functions of controlling oil, inhibiting the growth of Malassezia bacteria, clearing inflammation and promoting blood circulation.
本发明的另一目的在于提供上述一种防脱发中药组合物的制备方法。采用微射流破壁提取法,即将中药混合物进行膨爆提取后,离心过滤,再用膜浓缩-大孔树脂吸附-膜浓缩,得到中药组合物。Another object of the present invention is to provide a preparation method of the above-mentioned anti-hair loss traditional Chinese medicine composition. A micro-jet wall-breaking extraction method is adopted, that is, the Chinese medicine mixture is subjected to expansion and explosion extraction, centrifugal filtration, membrane concentration-macroporous resin adsorption-membrane concentration, and the Chinese medicine composition is obtained.
本发明的再一目的在于提供上述一种防脱发中药组合物在化妆品中的应用。Another object of the present invention is to provide the application of the above-mentioned traditional Chinese medicine composition for preventing hair loss in cosmetics.
本发明的再一目的在于提供一种含上述防脱发中药组合物的头发洗护液。Another object of the present invention is to provide a hair lotion containing the above-mentioned anti-hair loss traditional Chinese medicine composition.
本发明目的通过以下技术方案实现:The object of the invention is achieved through the following technical solutions:
一种防脱发中药组合物,由如下重量份的组分制成:射干5~50份;土槿皮5~35份;三颗针5~35份;徐长卿5~35份;甘草5~35份。A traditional Chinese medicine composition for preventing hair loss, which is made of the following components in parts by weight: 5-50 parts of shegan; 5-35 parts of hibiscus bark; 5-35 parts of three needles; share.
优选地,所述的防脱发中药组合物,由如下重量份的组分制成:射干10~45份;土槿皮7~30份;三颗针7~30份;徐长卿5~30份;甘草5~30份。Preferably, the anti-hair loss traditional Chinese medicine composition is made of the following components by weight: Shegan 10-45 parts; Hibiscus bark 7-30 parts; Three needles 7-30 parts; Xu Changqing 5-30 parts; 5-30 parts of licorice.
进一步优选地,所述的防脱发中药组合物,由如下重量份的组分制成:射干15~40份;土槿皮10~25份;三颗针10~25份;徐长卿10~30份;甘草10~25份。Further preferably, the anti-hair loss traditional Chinese medicine composition is made of the following components by weight: Shegan 15-40 parts; Hibiscus bark 10-25 parts; Three needles 10-25 parts; Xu Changqing 10-30 parts ; 10-25 parts of licorice.
进一步优选地,所述的防脱发中药组合物,由如下重量份的组分制成:射干25~30份;土槿皮15~20份;三颗针15~20份;徐长卿18~25份;甘草15~22份。Further preferably, the anti-hair loss traditional Chinese medicine composition is made of the following components by weight: Shegan 25-30 parts; Hibiscus bark 15-20 parts; Three needles 15-20 parts; Xu Changqing 18-25 parts ; licorice 15 to 22 parts.
上述一种防脱发中药组合物的制备方法,包括如下步骤:The preparation method of above-mentioned a kind of anti-hair loss Chinese medicine composition, comprises the steps:
①配料:将射干、土槿皮、三颗针、徐长卿和甘草分别除杂,清洗,烘干,粉碎后过40~100目筛,然后混匀,得到中药混合物;①Ingredients: Remove impurities from Shegan, Tujinpi, Sanjiazhen, Xu Changqing and Licorice respectively, wash, dry, crush, pass through a 40-100 mesh sieve, and then mix to obtain a Chinese medicine mixture;
②提取:将中药混合物和1,3-丁二醇混合均匀,浸泡,然后将中药混合物和1,3-丁二醇的混合液通过微射流提取器进行提取,离心,过滤,弃沉淀,收集滤液;②Extraction: Mix the Chinese medicine mixture and 1,3-butanediol evenly, soak, then extract the mixture of Chinese medicine mixture and 1,3-butanediol through a micro-fluidic extractor, centrifuge, filter, discard the precipitate, and collect filtrate;
③浓缩:取滤液,用膜浓缩,即得中药组合物。③ Concentration: Take the filtrate and concentrate it with a membrane to obtain the traditional Chinese medicine composition.
优选地,步骤①中所述除杂、清洗、烘干和粉碎均采用本领域常规方法。Preferably, the impurity removal, cleaning, drying and pulverization in step ① all adopt conventional methods in the art.
优选地,步骤②中所述中药混合物和1,3-丁二醇按1:1~15重量配比,浸泡时间为1~5小时;所述离心转速为1000~3000转/min,离心时间为0.5~10min。Preferably, the traditional Chinese medicine mixture and 1,3-butanediol in step ② are in a weight ratio of 1:1 to 15, and the soaking time is 1 to 5 hours; the centrifugation speed is 1000 to 3000 rpm, and the centrifugation time 0.5 to 10 minutes.
优选地,步骤②中所述微射流提取器为专利CN107537180A中所述的微射流提取器。Preferably, the microfluidic extractor described in step ② is the microfluidic extractor described in the patent CN107537180A.
优选地,步骤③中所述滤液用膜浓缩至步骤②中药混合物重量的1~3倍。Preferably, the filtrate in step ③ is concentrated with a membrane to 1-3 times the weight of the traditional Chinese medicine mixture in step ②.
优选地,步骤③中所述用膜浓缩采用本领域常规方法。Preferably, the membrane concentration described in step ③ adopts conventional methods in the art.
优选地,步骤①~③均在室温下进行。Preferably, steps ①~③ are all carried out at room temperature.
上述一种防脱发中药组合物在化妆品中的应用。Application of the above-mentioned anti-hair loss traditional Chinese medicine composition in cosmetics.
优选地,所述应用为:将上述一种防脱发中药组合物用于制备化妆品,其中防脱发中药组合物占化妆品重量的0.1~60%。Preferably, the application is: using the above-mentioned anti-hair loss traditional Chinese medicine composition for preparing cosmetics, wherein the anti-hair loss traditional Chinese medicine composition accounts for 0.1-60% by weight of the cosmetic.
优选地,所述防脱发中药组合物占化妆品重量的1~30%。Preferably, the anti-hair loss traditional Chinese medicine composition accounts for 1-30% by weight of the cosmetic.
一种防脱发化妆品,其成分中含有上述防脱发中药组合物,所述防脱发中药组合物在所述防脱发化妆品中的重量含量为0.1~60%。An anti-hair loss cosmetic, which contains the above-mentioned anti-hair loss traditional Chinese medicine composition, and the weight content of the anti-hair loss traditional Chinese medicine composition in the anti-hair loss cosmetic is 0.1-60%.
优选地,所述防脱发中药组合物在所述防脱发化妆品中的重量含量为1~30%。Preferably, the weight content of the anti-hair loss traditional Chinese medicine composition in the anti-hair loss cosmetic is 1-30%.
优选地,所述防脱发化妆品为洗护发类化妆品;所述洗护发类化妆品为水剂、乳液类、膏霜类、喷雾类、精华类和皂类中的一种。Preferably, the anti-hair loss cosmetics are hair care cosmetics; the hair care cosmetics are one of lotions, emulsions, creams, sprays, essences and soaps.
一种护发防脱营养水,由如下质量份数计的组分组成:A hair care and anti-loss nutritional water, which consists of the following components in parts by mass:
所述氢化蓖麻油CO40为聚氧乙烯40氢化蓖麻油。The hydrogenated castor oil CO40 is polyoxyethylene 40 hydrogenated castor oil.
一种头皮护理防脱洗头水,由如下质量份数计的组分组成:An anti-shedding shampoo for scalp care, which consists of the following components in parts by mass:
所述聚季铵盐-5为N,N,N-三甲基-2-[(2-甲基-1-氧-2-丙烯基)氧]乙铵甲磺酸酯与2-丙烯酰胺的聚合物。The polyquaternium-5 is N,N,N-trimethyl-2-[(2-methyl-1-oxygen-2-propenyl)oxy]ethylammonium methanesulfonate and 2-acrylamide of polymers.
一种头皮护理防脱护发素,由如下质量分数计的组分组成:A scalp care anti-hair loss conditioner, consisting of the following components in terms of mass fractions:
所述十六十八醇中十六醇和十八醇的质量比为3:7。The mass ratio of cetyl alcohol to stearyl alcohol in the cetostearyl alcohol is 3:7.
所述聚季铵盐-37为N,N,N-三甲基-2-[(2-甲基-1-氧-2-丙烯基)氧]乙铵甲磺酸酯的均聚物。The polyquaternium-37 is a homopolymer of N,N,N-trimethyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]ethylammonium methanesulfonate.
本发明所述一种防脱发中药组合物是以君臣佐使的中医组方理论为指导,精选了射干、土槿皮、三颗针、徐长卿、甘草按照一定的比例进行配伍得到。本发明组合物中射干为君药,具有清热解毒、散结消炎、消肿止痛功效,达到控油、清除头皮粉刺和治疗毛囊炎目的;土槿皮和三棵针为臣药,土槿皮和三棵针都具有清热利湿、抗菌、散瘀功效,辅助达到达到控油、清除头皮粉刺和治疗毛囊炎目的;徐长卿为佐药,具有祛风止痒、通经活血功效,达到赋活毛根目标;甘草为使药,具有益气补中、缓急止痛、泻火解毒、调和诸药功效。The traditional Chinese medicine composition for preventing hair loss described in the present invention is guided by the theory of TCM prescriptions of Jun Chen Zuo Shi, and is obtained by selecting She Gan, Tu Hibiscus Pi, Three Needles, Xu Changqing and Licorice according to a certain proportion. In the composition of the present invention, Shegan is the monarch drug, which has the effects of clearing away heat and detoxification, dispelling stagnation, reducing inflammation, reducing swelling and relieving pain, and achieves the purpose of oil control, removing scalp acne and treating folliculitis; All three needles have the effects of clearing away heat and promoting dampness, antibacterial, and dispersing blood stasis, helping to achieve the purpose of oil control, clearing scalp acne, and treating folliculitis; Xu Changqing is an adjuvant drug, which has the effects of dispelling wind, relieving itching, dredging menstrual flow and activating blood circulation, and achieving the goal of revitalizing hair roots Glycyrrhiza licorice is used as medicine, has the effects of nourishing qi and invigorating the middle, relieving spasm and relieving pain, purging fire and detoxification, and harmonizing various medicines.
与现有技术相比,本发明具有以下优点及有益效果:Compared with the prior art, the present invention has the following advantages and beneficial effects:
本发明所述防脱发中药组合物中所述组分按照特定比例进行搭配,达到协同增效的作用,利用中药组合物的杀菌和控油功效去除头皮粉刺、治疗毛囊炎从而防脱发,利用中药组合物的活血功效赋活毛根从而促进毛发生长,利用中药组合物的抗菌作用和抗氧化作用达到去头皮屑功效,从而达到脱发综合治疗目标。The components in the anti-hair loss Chinese medicine composition of the present invention are matched according to a specific ratio to achieve a synergistic effect. Utilizing the bactericidal and oil-controlling effects of the Chinese medicine composition to remove scalp acne and treat folliculitis so as to prevent hair loss, use the combination of Chinese medicine The anti-dandruff effect is achieved by using the anti-bacterial and anti-oxidative effects of the traditional Chinese medicine composition, so as to achieve the goal of comprehensive treatment of hair loss.
附图说明Description of drawings
图1为实施例1所得中药组合物、对比例6~9所得中药组合物的色泽对比图。Fig. 1 is a color comparison diagram of the traditional Chinese medicine composition obtained in Example 1 and the traditional Chinese medicinal composition obtained in Comparative Examples 6-9.
具体实施方式Detailed ways
下面结合实施例和附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。The present invention will be further described in detail below with reference to the examples and drawings, but the implementation of the present invention is not limited thereto.
本申请实施例和对比例中未注明具体实验条件的试验方法,均按照本领域常规实验条件方法进行操作。The test methods for which specific experimental conditions are not indicated in the examples and comparative examples of the present application are all operated according to conventional experimental conditions and methods in this field.
实施例1一种防脱发中药组合物(Ⅰ)Embodiment 1 A kind of anti-hair loss Chinese medicine composition (I)
一种防脱发中药组合物,由如下重量份的组分制成:射干30份;土槿皮15份;三颗针15份;徐长卿20份;甘草20份。A traditional Chinese medicine composition for preventing hair loss, which is prepared from the following components in parts by weight: 30 parts of shegan; 15 parts of hibiscus bark; 15 parts of three needles; 20 parts of Xu Changqing; 20 parts of licorice.
实施例2一种防脱发中药组合物(Ⅱ)Embodiment 2 A kind of anti-hair loss Chinese medicine composition (Ⅱ)
一种防脱发中药组合物,由如下重量份的组分制成:射干25份;土槿皮20份;三颗针15份;徐长卿25份;甘草15份。A traditional Chinese medicine composition for preventing hair loss, which is prepared from the following components in parts by weight: 25 parts of shegan; 20 parts of hibiscus bark; 15 parts of three needles; 25 parts of Xu Changqing; 15 parts of licorice.
实施例3一种防脱发中药组合物(Ⅲ)Embodiment 3 A kind of anti-hair loss Chinese medicine composition (Ⅲ)
一种防脱发中药组合物,由如下重量份的组分制成:射干25份;土槿皮15份;三颗针20份;徐长卿18份;甘草22份。A traditional Chinese medicine composition for preventing hair loss, which is prepared from the following components in parts by weight: 25 parts of shegan; 15 parts of hibiscus bark; 20 parts of three needles; 18 parts of Xu Changqing; 22 parts of licorice.
实施例4一种防脱发中药组合物(Ⅳ)Embodiment 4 A kind of anti-hair loss Chinese medicine composition (Ⅳ)
一种防脱发中药组合物,由如下重量份的组分制成:射干30份;土槿皮15份;三颗针18份;徐长卿20份;甘草17份。A traditional Chinese medicine composition for preventing hair loss, which is prepared from the following components in parts by weight: 30 parts of shegan; 15 parts of hibiscus bark; 18 parts of three needles; 20 parts of Xu Changqing; 17 parts of licorice.
实施例1~4制备方法:室温条件下,将中药材原料分别除杂、清洗、烘干、粉碎后,过60目筛,混合均匀,得中药混合物,加入常规提取罐中,加入中药混合物重量10倍的1,3-丁二醇进行浸泡3小时,然后将中药混合物和1,3-丁二醇的混合液通过微射流提取器(参见专利CN107537180A)进行提取(室温下连续式微射流破壁提取),然后在2000转/min下离心2min并过滤后,滤液用膜浓缩至中药混合物重量的2倍,即为本发明提供的中药组合物。Examples 1-4 Preparation method: Under room temperature conditions, remove impurities, wash, dry, and pulverize the raw materials of Chinese medicinal materials respectively, pass through a 60-mesh sieve, and mix evenly to obtain a Chinese medicine mixture, add it to a conventional extraction tank, and add the weight of the Chinese medicine mixture 10 times of 1,3-butanediol was soaked for 3 hours, and then the mixture of traditional Chinese medicine mixture and 1,3-butanediol was extracted by a micro-fluidic extractor (see patent CN107537180A) (continuous micro-jet broken wall at room temperature extraction), then centrifuged at 2000 rpm for 2min and filtered, and the filtrate was concentrated to 2 times the weight of the Chinese medicine mixture with a membrane, which was the Chinese medicine composition provided by the invention.
对比例1~5单味中药提取液Comparative example 1-5 single Chinese medicine extract
成分见表1所示。The ingredients are shown in Table 1.
表1Table 1
按照实施例1~4所述的制备方法依次制得对比例1~5对应的射干、土槿皮、三颗针、徐长卿、甘草的提取液,即得单味中药提取液。According to the preparation methods described in Examples 1 to 4, the extracts of Shegan, Tujinpi, Sangezhen, Xu Changqing and Licorice corresponding to Comparative Examples 1 to 5 were sequentially prepared to obtain single herbal extracts.
对比例6~9Comparative example 6-9
对比例6为将实施例1制备方法中的1,3-丁二醇改为去离子水,其余条件与实施例1完全一致,得到中药提取液,即为中药组合物。In Comparative Example 6, the 1,3-butanediol in the preparation method of Example 1 was changed to deionized water, and the rest of the conditions were completely consistent with those of Example 1 to obtain a Chinese medicine extract, which was a Chinese medicine composition.
对比例7为将实施例1制备方法中的1,3-丁二醇改为无水乙醇,其余条件与实施例1完全一致,得到中药提取液,即为中药组合物。In Comparative Example 7, the 1,3-butanediol in the preparation method of Example 1 was changed to absolute ethanol, and the rest of the conditions were completely consistent with those of Example 1 to obtain a Chinese medicine extract, which was a Chinese medicine composition.
对比例8为将对比例6获得的中药提取液用AB-8大孔树脂吸附,再用体积分数为20%、50%、95%的乙醇依次洗脱,收集洗脱液,将洗脱液采用膜浓缩至与大孔树脂吸附前中药提取液相同重量,得浓缩液,再加入与浓缩液相同重量的丁二醇溶解,过滤,得到中药提取液,即为中药组合物。Comparative example 8 is that the traditional Chinese medicine extract obtained in comparative example 6 is adsorbed with AB-8 macroporous resin, and then eluted successively with ethanol with a volume fraction of 20%, 50%, and 95%, and the eluate is collected, and the eluate Concentrating by membrane to the same weight as the traditional Chinese medicine extract before adsorption by the macroporous resin to obtain a concentrated solution, adding butanediol with the same weight as the concentrated solution to dissolve, filtering to obtain the traditional Chinese medicine extract, which is the traditional Chinese medicine composition.
对比例9为将对比例7获得的提取液用AB-8大孔树脂吸附,再用体积分数为20%、50%、95%的乙醇依次洗脱,收集洗脱液,将洗脱液膜浓缩至与大孔树脂吸附前中药提取液相同重量,得浓缩液,再加入与浓缩液相同重量的丁二醇溶解,过滤,得到中药提取液,即为中药组合物。Comparative Example 9 is to absorb the extract obtained in Comparative Example 7 with AB-8 macroporous resin, then elute sequentially with ethanol with a volume fraction of 20%, 50%, and 95%, collect the eluate, and separate the eluate from the membrane Concentrate to the same weight as the traditional Chinese medicine extract before adsorption by the macroporous resin to obtain a concentrated solution, then add butanediol with the same weight as the concentrated solution to dissolve, filter to obtain the traditional Chinese medicine extract, which is the Chinese medicine composition.
试验例1抑菌圈试验Test Example 1 Zone of Inhibition Test
测试方法为牛津杯法(也叫管碟法),此方法是国内外测定抗生素效价通用方法,也是多国药典规定的方法。通过抑菌圈测试,判断待测样品对马拉色菌(糠秕马拉色菌(糠秕孢子菌),拉丁文Malassezia furfur(Pityrosporum orbiculare),购买单位:广东省微生物菌种保藏中心,GIM2.181)的抑制作用。The test method is the Oxford cup method (also called the tube-and-dish method). This method is a common method for determining the potency of antibiotics at home and abroad, and it is also a method stipulated by multinational pharmacopoeias. Through the inhibition zone test, it is judged that the sample to be tested is resistant to Malassezia furfur (Malassezia furfur (Pityrosporum), Latin Malassezia furfur (Pityrosporum orbitale), purchase unit: Guangdong Microbial Culture Collection Center, GIM2.181 ) inhibition.
测试样品:实施例1~4和对比例1~5制备的产品用橄榄油稀释至5倍后作为待测样。Test samples: the products prepared in Examples 1-4 and Comparative Examples 1-5 were diluted to 5 times with olive oil as samples to be tested.
以无菌操作,将经过0.105MPa压力和121℃下灭菌30min的培养基倒入直径9cm的无菌培养皿中,使每个培养皿有15mL的培养基,冷却后,加入0.2mL马拉色菌菌悬液(105~106cfu/g),用涂布棒将培养基表面涂布均匀,用镊子将牛津杯垂直放在相应培养基表面,轻轻加压,使其与培养基接触无空隙,每个培养皿可放3支小管,分别向各小管中滴加0.1mL的各种待测样,并做好标记,勿使其外溢。马拉色菌:将上述实验培养皿置37℃培养箱厌氧培养2~5天后,观察结果。With aseptic operation, pour the culture medium that has been sterilized at 0.105MPa pressure and 121°C for 30min into sterile petri dishes with a diameter of 9cm, so that each petri dish has 15mL of culture medium. After cooling, add 0.2mL Mala Chromobacterium suspension (10 5 ~ 10 6 cfu/g), spread evenly on the surface of the culture medium with a coating stick, place the Oxford cup vertically on the surface of the corresponding culture medium with tweezers, press gently to make it compatible with the culture medium There are no gaps in the substrate contact, and each petri dish can hold 3 small tubes, and drop 0.1mL of various samples to be tested into each small tube, and mark it well to prevent it from overflowing. Malassezia: Put the above-mentioned experimental petri dish in a 37°C incubator for anaerobic culture for 2 to 5 days, and observe the results.
在培养时,一方面试验菌开始生长,另一方面待测样以牛津杯为原点向四周扩散,形成菌落不能生长的圆形区域,为“抑菌圈”。抑菌圈越大,祛痘效果越好。During cultivation, on the one hand, the test bacteria begin to grow, and on the other hand, the sample to be tested spreads around from the Oxford cup as the origin, forming a circular area where the colony cannot grow, which is the "inhibition zone". The larger the antibacterial zone, the better the effect of acne removal.
药敏实验的结果,按抑菌圈直径大小判定敏感度高低,判断标准参考下表2。The results of the drug susceptibility test are based on the diameter of the inhibition zone to determine the sensitivity level, and the judgment standard refers to the following table 2.
表2药物敏感实验判定标准Table 2 Judgment Criteria for Drug Sensitivity Test
培养5天后,测试结果,如表3所示。After culturing for 5 days, the test results are shown in Table 3.
表3抑菌圈试验测试结果Table 3 Bacterial inhibition zone test test results
结果表明,本发明中的实施例1~4抑制马拉色菌效果显著,说明中药组合物具有显著的抗菌消炎效果;而且均比对比例1~5所述的单味中药的效果好得多,说明中药经过科学组方后对马拉色菌抑制有协同增效作用。The results show that Examples 1 to 4 in the present invention have a significant effect on inhibiting Malassezia, indicating that the Chinese medicine composition has significant antibacterial and anti-inflammatory effects; and the effects of the single Chinese medicines described in Comparative Examples 1 to 5 are much better , indicating that the traditional Chinese medicine has a synergistic effect on the inhibition of Malassezia after scientific formulation.
试验例2抑制甾体5α-还原酶活性效果评价试验Test Example 2 Inhibition of Steroidal 5α-Reductase Activity Effect Evaluation Test
科学研究发现雄性激素,特别是双氢睾酮(简称DHT)这种特殊雄激素,过于亢进是导致脂溢性脱发的主要因素。而DHT合成过程需要甾体5α-还原酶参与,所以通过抑制甾体5α-还原酶活性即可抑制DHT合成,达到防脱发的目的。Scientific research has found that androgen, especially the special androgen of dihydrotestosterone (abbreviated as DHT), is too hyperactive to be the main factor leading to seborrheic alopecia. The DHT synthesis process requires the participation of steroidal 5α-reductase, so the synthesis of DHT can be inhibited by inhibiting the activity of steroidal 5α-reductase, so as to achieve the purpose of preventing hair loss.
测试样品:空白试验组(甾体5α-还原酶、依赖性还原辅酶(NADPH)、Tris缓冲溶液);空白对照组(睾丸酮乙醇溶液、甾体5α-还原酶、依赖性还原辅酶(NADPH)、Tris缓冲溶液);实施例1样品组(实施例1中药组合物水溶液、睾丸酮乙醇溶液、甾体5α-还原酶、依赖性还原辅酶(NADPH)、Tris缓冲溶液);对比例1~5样品组(对比例1~5中药提取物水溶液、睾丸酮乙醇溶液、甾体5α-还原酶、依赖性还原辅酶(NADPH)、Tris缓冲溶液);其中睾丸酮乙醇溶液的浓度为0.4μmol/L,实施例1中药组合物水溶液的浓度为0.5g/L,对比例1~5中药提取物水溶液的浓度均为0.5g/L;甾体5α-还原酶、依赖性还原辅酶(NADPH)、Tris缓冲溶液均按文献(孙祖越,郑维君,王晓麟.甾体5α-还原酶活性的新测定方法[J],中华内分泌代谢杂志,1998,14(3):206-207)所述方法配制。Test samples: blank test group (steroidal 5α-reductase, dependent reducing coenzyme (NADPH), Tris buffer solution); blank control group (testosterone ethanol solution, steroidal 5α-reductase, dependent reducing coenzyme (NADPH), Tris buffer solution); Example 1 sample group (embodiment 1 Chinese medicine composition aqueous solution, testosterone ethanol solution, steroidal 5α-reductase, dependent reducing coenzyme (NADPH), Tris buffer solution); Comparative example 1~5 sample groups (comparative example 1~5 Chinese medicine extract aqueous solution, testosterone ethanol solution, steroidal 5α-reductase, dependent reducing coenzyme (NADPH), Tris buffer solution); Wherein the concentration of testosterone ethanol solution is 0.4 μ mol/L, embodiment 1 The concentration of the aqueous solution of the Chinese medicine composition is 0.5g/L, and the concentration of the aqueous solution of the Chinese medicine extract of Comparative Examples 1 to 5 is 0.5g/L; It was prepared by the method described in the literature (Sun Zuyue, Zheng Weijun, Wang Xiaolin. A new assay method for steroidal 5α-reductase activity [J], Chinese Journal of Endocrinology and Metabolism, 1998, 14(3): 206-207).
按文献(孙祖越,郑维君,王晓麟.甾体5α-还原酶活性的新测定方法[J],中华内分泌代谢杂志,1998,14(3):206-207)方法进行试验:将以上各组反应体系分别于37℃下连续孵育,用紫外光栅分光光度计在340nm处连续测定NADPH的特征吸收波长OD值的时间变化曲线,根据NADPH标准曲线折算出作为酶学反应底物NADPH 10min内的浓度下降速率,扣除空白试验组的下降速率,即为酶活性。测定结果见表4所示。According to the literature (Sun Zuyue, Zheng Weijun, Wang Xiaolin. A new assay method for steroidal 5α-reductase activity [J], Chinese Journal of Endocrinology and Metabolism, 1998, 14(3): 206-207) to carry out the test: the above groups of reaction systems Continuously incubate at 37°C, measure the time-varying curve of the OD value of the characteristic absorption wavelength of NADPH continuously at 340nm with an ultraviolet grating spectrophotometer, and calculate the concentration drop rate of NADPH as the enzymatic reaction substrate within 10 minutes according to the NADPH standard curve , subtract the rate of decline of the blank test group, which is the enzyme activity. The measurement results are shown in Table 4.
表4甾体5α-还原酶活性Table 4 Steroidal 5α-reductase activity
表4结果表明,本发明实施例1的中药组合物对甾体5α-还原酶活性具有明显的抑制作用,其抑制作用明显优于对比例1~5所述的单味中药的抑制效果,说明中药经过科学组方后对甾体5α-还原酶活性抑制有协同增效作用。The results in Table 4 show that the Chinese medicine composition of Example 1 of the present invention has a significant inhibitory effect on steroidal 5α-reductase activity, and its inhibitory effect is significantly better than that of the single Chinese medicine described in Comparative Examples 1 to 5, indicating that The traditional Chinese medicine has a synergistic effect on the inhibition of steroidal 5α-reductase activity after scientific formulation.
试验例3清除自由基试验Test example 3 free radical scavenging test
1、试样的配制1. Sample preparation
分别将实施例1~4制备的产品配成质量浓度为1%的样品乙醇溶液,进行下面实验。The products prepared in Examples 1-4 were formulated into sample ethanol solutions with a mass concentration of 1%, and the following experiments were carried out.
2、对超氧阴离子自由基清除能力评价2. Evaluation of superoxide anion free radical scavenging ability
取0.05mol/L pH=8.2的Tris-HCl缓冲液4.5mL,于25℃水浴锅中预热20min。再加入1mL样品乙醇溶液和0.4mL 25mmol/L的邻苯三酚溶液,混匀后,于25℃水浴中反应5min,加入8mol/L的HCl 1.0mL终止反应。以Tris-HCl缓冲液(0.05mol/L pH=8.2)作参比,在299nm处测吸光度值。空白对照用1mL样品乙醇溶液的溶剂来替代样品,其他条件不变,进行上述操作,测得空白对照的吸光度值。Take 4.5 mL of 0.05 mol/L Tris-HCl buffer solution with pH=8.2, and preheat it in a water bath at 25°C for 20 min. Then add 1mL sample ethanol solution and 0.4mL 25mmol/L pyrogallol solution, mix well, react in a water bath at 25°C for 5min, and add 1.0mL 8mol/L HCl to terminate the reaction. Using Tris-HCl buffer solution (0.05mol/L pH=8.2) as a reference, the absorbance value was measured at 299nm. For the blank control, use 1mL sample ethanol solution as a solvent to replace the sample, and other conditions remain unchanged, carry out the above operations, and measure the absorbance value of the blank control.
超氧阴离子自由基清除率(%)=[1-(A2-A1)/A1]×100%Superoxide anion radical scavenging rate (%)=[1-(A2-A1)/A1]×100%
式中A1为空白对照的吸光度值;A2为样品的吸光度值。In the formula, A1 is the absorbance value of the blank control; A2 is the absorbance value of the sample.
3、对羟自由基的清除能力评价3. Evaluation of the ability to scavenge hydroxyl radicals
在25mL比色管中依次加入2mmol/L FeSO4溶液3mL,1mmol/L H2O2溶液3mL,摇匀,接着加入6mmol/L水杨酸溶液3mL,摇匀,于37℃水浴加热15min后取出,测其吸光度A3;然后加入1mL样品乙醇溶液,摇匀,继续水浴加热15min,取出测其吸光度A4。空白对照组为未加水杨酸溶液,其他条件不变,进行上述操作,测得吸光度A5。下式为待测液对羟自由基(·OH)的清除率:Add 3mL of 2mmol/L FeSO 4 solution and 3mL of 1mmol/L H 2 O 2 solution to a 25mL colorimetric tube successively, shake well, then add 3mL of 6mmol/L salicylic acid solution, shake well, heat in a water bath at 37°C for 15min, then take out , measure its absorbance A3; then add 1mL sample ethanol solution, shake well, continue heating in a water bath for 15min, take it out and measure its absorbance A4. The blank control group was no salicylic acid solution, and the other conditions remained unchanged. The above operations were carried out, and the absorbance A5 was measured. The following formula is the scavenging rate of the liquid to be tested to hydroxyl radicals (OH):
羟自由基清除率(%)=[A3-A4-(A3-A5)]/A3×100%Hydroxyl radical scavenging rate (%)=[A3-A4-(A3-A5)]/A3×100%
式中A3为未加样品前反应体系的吸光度值;A4为样品清除·OH后体系的吸光度值;A5为空白对照清除·OH后体系的吸光度值。In the formula, A3 is the absorbance value of the reaction system before no sample is added; A4 is the absorbance value of the system after the sample removes OH; A5 is the absorbance value of the system after the blank control removes OH.
4、样品抗自由基的对比测试4. Comparative test of samples against free radicals
表5自由基清除率功能评价结果Table 5 Functional evaluation results of free radical scavenging rate
实验表明,本发明的实施例1~4中药组合物对超氧阴离子和羟自由基具有良好的清除作用。Experiments show that the traditional Chinese medicine compositions of Examples 1 to 4 of the present invention have a good scavenging effect on superoxide anion and hydroxyl radical.
试验例4皮肤刺激性实验Test example 4 skin irritation test
实验材料:选用实施例1、对比例1~5样品用丁二醇溶解,制成质量分数为20%的溶液作为测试样品。Experimental materials: the samples of Example 1 and Comparative Examples 1-5 were dissolved in butanediol to prepare a solution with a mass fraction of 20% as a test sample.
受试者:共30名志愿者,其中女性:20名,男性10名,年龄在20~40岁。Subjects: 30 volunteers in total, including 20 females and 10 males, aged between 20 and 40 years old.
试验方法:用注射器取0.03mL测试样品置于斑试胶带的药室内,立即将置有测试样品的斑试胶带从下部开始纵向贴于左前臂的正常皮肤上,同时逐个轻压药室以驱除空气,并使试验物均匀分布。试验部位做好标记,以便观察。每隔24小时贴肤一次,揭开贴片后半个小时,则按照CTFA指南(1981年)的术语进行了检查。共进行了6次斑贴实验(每次都在同一个位置进行贴肤),贴肤结束后的第6天,为了观察迟发反应,进行了追加检查。数据则利用最后一次检查结果,进行了比较。鉴定以下表6为标准进行:Test method: Take 0.03mL test sample with a syringe and place it in the medicine chamber of the spot test tape, and immediately stick the spot test tape with the test sample on the normal skin of the left forearm longitudinally from the bottom, and at the same time lightly press the medicine chamber one by one to remove air, and distribute the test substance evenly. Mark the test site for easy observation. The skin was applied every 24 hours, and half an hour after the patch was removed, the inspection was carried out according to the terms of the CTFA guideline (1981). A total of 6 patch tests were performed (applied to the same position each time), and an additional examination was performed on the 6th day after the end of the patch to observe delayed reactions. Data were compared using the results of the last inspection. The identification is carried out according to the following table 6 as the standard:
表6皮肤刺激鉴定标准Table 6 Skin Irritation Identification Criteria
试验结果:如表7所示,其中0表述0等级,即无刺激、无红斑。Test results: as shown in Table 7, where 0 represents a grade of 0, that is, no irritation and no erythema.
表7皮肤刺激测试结果Table 7 Skin irritation test results
表7结果显示,本发明实施例1中药组合物样品未发现志愿者出现刺激,而且刺激性比对比例1~5单味中药样品低得多。由此可知,中药经过科学组合后,在用量一致的情况下,比单独使用更温和。The results in Table 7 show that no irritation was found in volunteers in the Chinese medicine composition sample of Example 1 of the present invention, and the irritation was much lower than that of the single Chinese medicine samples in Comparative Examples 1-5. It can be seen from this that the scientific combination of traditional Chinese medicine is milder than that used alone under the condition of consistent dosage.
试验例4控油效果评价试验Test Example 4 Oil Control Effect Evaluation Test
4.1试样的配制和仪器4.1 Sample preparation and instruments
实验材料:选用实施例1、对比例1~5样品用水溶解,制成质量分数为20%的溶液作为测试样品。Experimental materials: the samples of Example 1 and Comparative Examples 1-5 were dissolved in water to prepare a solution with a mass fraction of 20% as a test sample.
测试仪器为德国Courage+Khazaka公司(德国CK公司)制造的皮肤油脂含量Sebumeter测试探头。The test instrument is a Sebumeter test probe for skin oil content manufactured by German Courage+Khazaka Company (Germany CK Company).
4.2实验原理4.2 Experimental principle
皮肤油脂清除率测试可以准确地对控油产品的功效进行量化的数值比较。The Skin Oil Clearance Test allows for accurate quantitative numerical comparisons of the efficacy of oil control products.
4.3前额油脂清除率测试方法4.3 Test method of forehead grease removal rate
选取油性皮肤的志愿者30名,年龄在20~35岁,男女各半。志愿者于试验开始前30天不能使用任何控油产品,如化妆品或外用药品或内服保健品等。试验前,进入温度22±2℃,湿度50±5%的恒温恒湿房间内静坐30min,按随机表选取志愿者的左右额头,取眉间中线与距上眉缘1cm平行线的交叉点为测试中点,然后在测试中点向左向右并列各测试一个位置,取3个值的平均值作为前额0h的油脂数据,然后要求受试者按随机表分别于前额单侧使用测试样品贴敷15分钟后清洗,并在清洗后的30min,2h,4h各时间点进行油脂测试,空白对照为另一侧且只用去离子水贴敷并清洗。Select 30 volunteers with oily skin, aged between 20 and 35, half male and half male. Volunteers were not allowed to use any oil control products, such as cosmetics or external medicines or internal health care products, 30 days before the start of the test. Before the test, sit in a constant temperature and humidity room with a temperature of 22±2°C and a humidity of 50±5% for 30 minutes, select the left and right foreheads of the volunteers according to the random table, and take the intersection point of the midline between the eyebrows and the parallel line 1cm away from the upper eyebrow edge as Test the midpoint, then test one position side by side from the left to the right at the midpoint of the test, take the average of the three values as the fat data of the forehead 0h, and then ask the subjects to use the test sample stickers on one side of the forehead according to the random table Wash after 15 minutes of application, and perform grease test at each time point of 30min, 2h, and 4h after washing. The blank control is the other side, which is only applied and washed with deionized water.
4.4测试结果4.4 Test results
表8前额油脂减少量(%)Table 8 forehead fat reduction (%)
表8数据显示,实施例1具有明显的抑制皮肤油脂分泌的功效,而且比对比例1~5对皮肤油脂分泌的抑制效果显著,说明中药经过科学组方后控油效果有协同增效作用。The data in Table 8 shows that Example 1 has an obvious effect of inhibiting skin oil secretion, and comparative examples 1 to 5 have a significant inhibitory effect on skin oil secretion, indicating that the oil control effect of traditional Chinese medicine has a synergistic effect after scientific formulation.
试验例5色泽和电导率测定试验Test Example 5 Color and conductivity determination test
天然物质提取液电导率是影响化妆品稳定性的重要因素,色泽则是影响化妆品外观的重要因素,所以化妆品使用的天然物质提取液要控制电导率和色泽。The conductivity of natural substance extracts is an important factor affecting the stability of cosmetics, and the color is an important factor affecting the appearance of cosmetics. Therefore, the conductivity and color of natural substance extracts used in cosmetics should be controlled.
用电导率仪测定实施例1和对比例6~9样品的电导率,结果见表9所示。The conductivity of the samples of Example 1 and Comparative Examples 6-9 was measured with a conductivity meter, and the results are shown in Table 9.
表9Table 9
由表9可知,用实施例1的电导率比对比例6~7小得多,与对比例8~9相当,说明用1,3-丁二醇做溶剂比水或乙醇可获得更低电导率的提取液,甚至还稍优于水或乙醇做溶剂并经过进一步纯化处理的提取物的电导率。1,3-丁二醇的电导率为1.32μS/cm,去离子水的电导率为2.78μS/cm。It can be seen from Table 9 that the conductivity of Example 1 is much smaller than that of Comparative Examples 6 to 7, and is equivalent to that of Comparative Examples 8 to 9, indicating that using 1,3-butanediol as a solvent can obtain lower conductivity than water or ethanol The conductivity of the extract is even slightly better than that of water or ethanol as solvent and further purified extract. The conductivity of 1,3-butanediol is 1.32 μS/cm, and that of deionized water is 2.78 μS/cm.
图1为实施例1所得中药组合物、对比例6~9所得中药组合物的色泽对比图,从图中可以看出,实施例1的色泽比对比例6~7浅得多,与对比例8~9相当。Fig. 1 is the color comparison diagram of the Chinese medicine composition obtained in Example 1 and the Chinese medicine composition obtained in Comparative Examples 6 to 9. As can be seen from the figure, the color of Example 1 is much lighter than that of Comparative Examples 6 to 7, and it is much lighter than that of Comparative Examples 6 to 7. 8 to 9 are equivalent.
说明用1,3-丁二醇做溶剂直接提取获得的提取液的色泽和电导率就可达到化妆品用天然物质提取液的要求,可省去了繁琐的纯化步骤。It shows that the color and conductivity of the extract obtained by direct extraction with 1,3-butanediol as a solvent can meet the requirements of natural substance extracts for cosmetics, and cumbersome purification steps can be omitted.
应用实施例1护发防脱营养水Application example 1 Hair care and anti-loss nutrient water
一种含有实施例1所述的防脱发中药组合物的护发防脱营养水,具体配方如表10所示:A kind of anti-hair loss nutrient water containing the anti-hair loss Chinese medicine composition described in embodiment 1, the specific formula is as shown in table 10:
表10Table 10
其中,硅油DC949购买于道康宁(上海)有限公司,氢化蓖麻油CO40购买于巴斯夫中国有限公司。Among them, silicone oil DC949 was purchased from Dow Corning (Shanghai) Co., Ltd., and hydrogenated castor oil CO40 was purchased from BASF China Co., Ltd.
制备方法:Preparation:
(1)将A组分物料加热升温至85℃,保温30min,搅拌溶解完全;(1) Heat the material of component A to 85°C, keep it warm for 30 minutes, stir and dissolve completely;
(2)将B组分物料加热升温至85℃,搅拌溶解完全;(2) Heat the material of component B to 85°C, stir and dissolve completely;
(3)将B组分加入到A组分中,均质5min,搅拌,降温至50℃,加入C、D组分,搅拌均匀,降温至38℃,即可得到护发防脱营养水。(3) Add component B to component A, homogenize for 5 minutes, stir, cool down to 50°C, add components C and D, stir evenly, cool down to 38°C, and you can get hair care and anti-hair loss nutritional water.
应用对比例1普通护发防脱营养水Application Comparative Example 1 Ordinary hair care anti-dehydration nutrient water
除了不含有本发明的中药组合物外,其他条件与应用实施例1一致。Except not containing the traditional Chinese medicine composition of the present invention, other conditions are consistent with Application Example 1.
应用实施例2头皮护理防脱洗头水Application example 2 Scalp care anti-shedding shampoo
一种含有实施例2所述的防脱发中药组合物的头皮护理防脱洗头水,具体配方如表11所示:A scalp care and anti-shedding shampoo containing the anti-hair loss Chinese medicine composition described in Example 2, the specific formula is as shown in Table 11:
表11Table 11
应用实施例3头皮护理防脱护发素Application Example 3 Scalp Care Anti-Hairfall Conditioner
一种含有实施例3所述的防脱发中药组合物的头皮护理防脱护发素,具体配方如表12所示:A kind of scalp care anti-hair loss conditioner containing the anti-hair loss Chinese medicine composition described in embodiment 3, the specific formula is as shown in table 12:
表12Table 12
其中,十六十八醇中十六醇和十八醇的质量比3:7。Among them, the mass ratio of cetyl alcohol to stearyl alcohol in cetostearyl alcohol is 3:7.
头皮效果评价Scalp Effect Evaluation
评价样品:应用实施例1(护发防脱营养水)和应用对比例1(普通护发防脱营养水)制备的产品。Evaluation samples: the products prepared in application example 1 (hair care and anti-loss nutrient water) and application comparative example 1 (common hair loss and anti-loss nutrient water).
评价方法:选取40名脂溢性脱发的受试者,均为男性,年龄在30~45岁,使用方法为每次洗头后,将样品喷于头皮上,按摩头皮5分钟。使用2个月后(每天使用一次),从脱发改善度、头皮滋润度、头皮清爽度、头皮粉刺改善度、头发毛躁改善度五个方面进行评价。Evaluation method: Select 40 subjects with seborrheic alopecia, all of them are male, aged 30-45 years old. The method of use is to spray the sample on the scalp after each shampoo and massage the scalp for 5 minutes. After using it for 2 months (once a day), evaluate from five aspects: hair loss improvement, scalp moisturization, scalp refreshment, scalp acne improvement, and hair frizz improvement.
评价标准:1分-差,2分-较差,3分-一般,4分-较好,5分-很好。Evaluation criteria: 1 point - poor, 2 points - poor, 3 points - average, 4 points - good, 5 points - very good.
评价结果:见表13所示。Evaluation results: see Table 13.
表13评价结果Table 13 Evaluation Results
由表13结果可知,应用实施例1产品脱发改善度、清爽度、头皮粉刺改善度和头发毛躁改善度都明显优于应用对比例1。说明添加有本发明的中药组合物可以改善脱发,改善头发毛躁,改善头皮粉刺,同时不油腻,起到头皮护理防脱发的作用。From the results in Table 13, it can be seen that the degree of improvement in hair loss, refreshment, scalp acne and hair frizz in Example 1 is significantly better than that in Comparative Example 1. It shows that adding the traditional Chinese medicine composition of the present invention can improve hair loss, improve hair frizz, improve scalp acne, and is not greasy at the same time, and plays the role of scalp care and anti-hair loss.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910805840.8A CN110420154A (en) | 2019-08-29 | 2019-08-29 | A kind of Anti-hair loss traditional Chinese medicine composition and the preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910805840.8A CN110420154A (en) | 2019-08-29 | 2019-08-29 | A kind of Anti-hair loss traditional Chinese medicine composition and the preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110420154A true CN110420154A (en) | 2019-11-08 |
Family
ID=68416438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910805840.8A Pending CN110420154A (en) | 2019-08-29 | 2019-08-29 | A kind of Anti-hair loss traditional Chinese medicine composition and the preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110420154A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992016186A1 (en) * | 1991-03-14 | 1992-10-01 | Lvmh Recherche | Cosmetic or pharmaceutical, especially dermatological, composition,containing oxyacanthine, in particular for stimulating hair growth or retarding hair loss |
JPH07138181A (en) * | 1993-11-15 | 1995-05-30 | Ichimaru Pharcos Co Ltd | Inhibitor of testosterone 5alpha-reductase containing extract from belamcanda chinensis dc. and its application |
CN101115493A (en) * | 2005-08-12 | 2008-01-30 | 河乃建仁 | Agent for hair growth |
CN104095792A (en) * | 2014-07-22 | 2014-10-15 | 广州好迪集团有限公司 | Hair conditioner capable of nourishing hair and repairing damage |
CN104800138A (en) * | 2014-01-24 | 2015-07-29 | Act株式会社 | Preparation method for submicroemulsion containing golden silkworm cocoon extract, and cosmetic composition |
CN107115397A (en) * | 2017-06-27 | 2017-09-01 | 李建国 | A kind of traditional Chinese medicine powder of hair growth |
CN108272725A (en) * | 2018-04-10 | 2018-07-13 | 成都卓蓝雅商务信息咨询有限公司 | A kind of submissive hair conditioner of yellow ginger and preparation method thereof |
CN109381375A (en) * | 2018-11-15 | 2019-02-26 | 广东轻工职业技术学院 | A kind of scalp care essential oil composition and application |
CN110090170A (en) * | 2018-06-26 | 2019-08-06 | 浙江立恩生物科技有限公司 | Biological polyoses and its application with hair growing anticreep |
-
2019
- 2019-08-29 CN CN201910805840.8A patent/CN110420154A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992016186A1 (en) * | 1991-03-14 | 1992-10-01 | Lvmh Recherche | Cosmetic or pharmaceutical, especially dermatological, composition,containing oxyacanthine, in particular for stimulating hair growth or retarding hair loss |
JPH07138181A (en) * | 1993-11-15 | 1995-05-30 | Ichimaru Pharcos Co Ltd | Inhibitor of testosterone 5alpha-reductase containing extract from belamcanda chinensis dc. and its application |
CN101115493A (en) * | 2005-08-12 | 2008-01-30 | 河乃建仁 | Agent for hair growth |
CN104800138A (en) * | 2014-01-24 | 2015-07-29 | Act株式会社 | Preparation method for submicroemulsion containing golden silkworm cocoon extract, and cosmetic composition |
CN104095792A (en) * | 2014-07-22 | 2014-10-15 | 广州好迪集团有限公司 | Hair conditioner capable of nourishing hair and repairing damage |
CN107115397A (en) * | 2017-06-27 | 2017-09-01 | 李建国 | A kind of traditional Chinese medicine powder of hair growth |
CN108272725A (en) * | 2018-04-10 | 2018-07-13 | 成都卓蓝雅商务信息咨询有限公司 | A kind of submissive hair conditioner of yellow ginger and preparation method thereof |
CN110090170A (en) * | 2018-06-26 | 2019-08-06 | 浙江立恩生物科技有限公司 | Biological polyoses and its application with hair growing anticreep |
CN109381375A (en) * | 2018-11-15 | 2019-02-26 | 广东轻工职业技术学院 | A kind of scalp care essential oil composition and application |
Non-Patent Citations (2)
Title |
---|
郑晓晖等: "39种中草药对马拉色菌抑菌实验研究", 《中国中西医结合皮肤性病学杂志》 * |
韩长日: "《化妆品生产工艺与技术》", 31 July 2019, 科学技术文献出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110292552B (en) | Compound plant extract with anti-allergy repairing effect and preparation method and application thereof | |
CN110237121B (en) | Traditional Chinese medicine composition for removing mites and removing acnes as well as preparation method and application thereof | |
CN108904376B (en) | Traditional Chinese medicine compound fermentation liquor for cosmetics with oil control and acne removal effects and preparation and application thereof | |
CN111631993B (en) | Composition containing sophora flavescens and magnolia officinalis extracts and cosmetic using composition | |
CN108815072B (en) | Fresh plant composition fermented raw pulp with moisturizing and relieving effects and preparation method and application thereof | |
CN115252649B (en) | Application of thermophilic bacteria fermentation product in preventing alopecia and/or growing hair, composition and preparation thereof | |
CN116370525B (en) | A plant fermentation composition for preventing hair loss and promoting hair growth, and its preparation method and application | |
CN110974775A (en) | Allergy-relieving composition containing nostoc sphaeroides and preparation method and application thereof | |
CN106236676B (en) | Plant composition with anti-aging effect and application thereof | |
CN111743830A (en) | Acne-removing composition and application thereof | |
CN113288835A (en) | Traditional Chinese medicine composition for relieving and repairing and preparation method and application thereof | |
CN118662418B (en) | Natural plant extract composition for preventing alopecia and fixing hair, and preparation method and application thereof | |
CN110420154A (en) | A kind of Anti-hair loss traditional Chinese medicine composition and the preparation method and application thereof | |
CN108703911B (en) | Composition with moisturizing and whitening effects and preparation method and application thereof | |
WO2020097982A1 (en) | Essential oil composition for scalp care and use | |
TWI620567B (en) | External composition for skin containing ginsenoside rf | |
CN110200870A (en) | A kind of reparation moisture retention water containing solanum lyratum and Flos Hibisci extract | |
CN116407476A (en) | Composition for removing dandruff, relieving itching and soothing, and preparation method and application thereof | |
CN109276519A (en) | A kind of paris polyphylla fermenation raw liquid and its preparation method and application | |
KR100368126B1 (en) | Composition capable of inhibiting sebum secretion | |
CN114569522A (en) | Hair loss prevention and hair growth plant composition and application | |
CN115006309B (en) | Microcirculation-improving whitening composition, microcirculation-improving whitening essence, and preparation methods and applications thereof | |
CN114129478B (en) | Application of cortex cinnamomi japonici extract in shampoo | |
CN116035967A (en) | Plant composition fermentation broth with after-sun restoration effect and preparation method and application thereof | |
CN113750013B (en) | Anti-hair-loss hair-growing composition and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191108 |
|
RJ01 | Rejection of invention patent application after publication |